A Phase I Study Using Bortezomib (velcade), Cladribine, and Rituximab in Treating Patients over 50 Years Old with Mantle Cell Lymphoma
FRONTIERS IN ONCOLOGY（2024）
Key words
mantle cell lymphoma (MCL),epigenetic,combination (combined) therapy,phase I trial,cladribine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined